AGP Executive Report
Last update: 3 hours agoAutism/ADHD Screening Breakthrough: A 17-year-old New Jersey student, Edward Kang, won major recognition for RetinaMind, an AI tool that screens for autism spectrum disorder and ADHD using retinal images. Opioid Treatment Access: A Rutgers study finds long-acting injectable buprenorphine use in New Jersey rose to nearly 5% of prescriptions, up from 0.7%, as researchers argue the monthly shots can help prevent overdoses for people who struggle with daily meds. Youth Social Media Lawsuit: Four states including New Jersey are seeking up to $1.4 trillion in penalties from Meta over claims Facebook/Instagram were designed to addict children. FDA Manufacturing Push: The FDA selected seven companies for its PreCheck Pilot Program to speed feedback on new U.S. drug manufacturing sites. NJ Health Alert—“Diarrhea Bug”: Cyclosporiasis cases tied to Cyclospora are rising, with officials still working to identify the source in New Jersey and across the U.S. Public Health & Safety: A serious crash on I-78 in Bedminster sent a motorcyclist to Robert Wood Johnson University Hospital after a helicopter response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.